Bifunctional role of Rev-erbalpha in adipocyte differentiation - PubMed (original) (raw)
Bifunctional role of Rev-erbalpha in adipocyte differentiation
Jing Wang et al. Mol Cell Biol. 2008 Apr.
Abstract
The nuclear receptor Rev-erbalpha is a potent transcriptional repressor that regulates circadian rhythm and metabolism. Here we demonstrate a dissociation between Rev-erbalpha mRNA and protein levels that profoundly influences adipocyte differentiation. During adipogenesis, Rev-erbalpha gene expression initially declines and subsequently increases. Remarkably, Rev-erbalpha protein levels are nearly the opposite, increasing early in adipogenesis and then markedly decreasing in adipocytes. The Rev-erbalpha protein is necessary for the early mitotic events that are required for adipogenesis. The subsequent reduction in Rev-erbalpha protein, due to increased degradation via the 26S proteasome, is also required for adipocyte differentiation because Rev-erbalpha represses the expression of PPARgamma2, the master transcriptional regulator of adipogenesis. Thus, opposite to what might be predicted from Rev-erbalpha gene expression, Rev-erbalpha protein levels must rise and then fall for adipocyte differentiation to occur.
Figures
FIG. 1.
Uncoupling of Rev-erbα mRNA and protein expressions during adipogenesis. (A) Quantitative RT-PCR showing initial repression and subsequent induction of Rev-erbα mRNA during normal 3T3-L1 adipocyte differentiation. (B) Western blot assay showing the initial decline and the subsequent decrease in Rev-erbα protein during adipogenesis. β-Actin served as a loading control, and aP2 was a positive control for differentiation. (C) Rev-erbα protein levels in adipocytes are increased by a 4-h treatment with the proteasome inhibitor MG132 at 20 μM. Ethanol (EtOH) was the solvent and served as a vehicle control.
FIG. 2.
Knockdown of endogenous Rev-erbα blocks adipocyte differentiation. (A) Quantitative PCR and Western blot assay showing knockdown of Rev-erbα in 3T3-L1 preadipocytes with a control β-gal- or Rev-erbα-specific shRNA. *, P < 0.05 (n = 3). (B) Phase-contrast microscopy and Oil Red O staining of day 7 3T3-L1 cells treated with control β-gal shRNA (upper panels) or Rev-erbα shRNA (lower panels). (C) Preadipocytes lacking Rev-erbα do not undergo the cell division normally required for adipogenesis. BrdU incorporation at day 2 in cells treated with no shRNA, β-gal control shRNA, or specific Rev-erbα shRNA is shown. Black bars indicate growth medium (GM), which was the negative control; gray bars indicate treatment with differentiation medium (DM). *, P < 0.05 (n = 3) compared with other shRNA treatments in differentiation medium. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
FIG. 3.
3T3-L1 cells conditionally expressing WT and degradation-resistant Rev-erbα. (A) Expression of Flag-tagged WT or degradation-resistant S55D/S59D (SD) Rev-erbα mRNA in Tet-off 3T3-L1 cells. Transgene expression is sensitive to inhibition by 2 μg/ml doxycycline (Dox). (B) Flag IP, followed by Western blotting, showing that the Tet-off WT and SD Rev-erbα proteins are also sensitive to doxycycline inhibition. (C) Western blot assay of WT and SD Rev-erbα proteins in Tet-off stable 3T3-L1 preadipocytes at various times after treatment with 20 μM CHX. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
FIG. 4.
Ectopic expression of degradation-resistant Rev-erbα blocks adipocyte differentiation. (A) Preadipocytes expressing WT or SD Rev-erbα expression vectors were differentiated for 9 days with or without 2 μg/ml doxycycline (Dox) and stained with Oil Red O. (B) aP2 mRNA levels in cells expressing ectopic WT and SD Rev-erbα. (C) aP2 protein levels in cells expressing ectopic WT and SD Rev-erbα. β-Actin served as a loading control. (D) Expression of the ectopic SD and WT Rev-erbα proteins during adipogenesis. β-Actin served as a loading control.
FIG. 5.
Rev-erbα expression represses PPARγ2. (A) Ectopic expression of degradation-resistant (SD), but not WT, Rev-erbα blocks PPARγ2 induction. (B) Retroviral expression of ectopic PPARγ2 in 3T3-L1 preadipocytes. (C) Ectopic expression of PPARγ2 rescues adipogenesis in 3T3-L1 cells ectopically expressing degradation-resistant SD Rev-erbα, as assessed by Oil Red O staining on day 7. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
FIG. 6.
Rev-erbα directly represses PPARγ2 promoter activity and expression. (A) Expression of PPARγ2-luciferase reporter transfected into 3T3-L1 preadipocytes along with 1 μg of either a WT or SD Rev-erbα expression plasmid or shRNA knockdown of endogenous Rev-erbα. Data shown are the averages of three independent experiments. Error bars represent standard deviations. (B) Ectopic expression of SD Rev-erbα in mature 3T3-L1 adipocytes reduces PPARγ2 and Bmal1 gene expression. *, P < 0.05 (n = 3). (C) shRNA knockdown of endogenous Rev-erbα increases the expression of the native PPARγ2 mRNA in preadipocytes, as well as a known Rev-erbα target gene, that for Bmal1. *, P < 0.05 (n = 3). (D) shRNA knockdown of endogenous Rev-erbα increases the expression of endogenous PPARγ2 protein in preadipocytes. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. Dox, doxycycline.
Similar articles
- The orphan nuclear receptor Rev-erbalpha recruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian Bmal1 gene.
Yin L, Lazar MA. Yin L, et al. Mol Endocrinol. 2005 Jun;19(6):1452-9. doi: 10.1210/me.2005-0057. Epub 2005 Mar 10. Mol Endocrinol. 2005. PMID: 15761026 - The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation.
Fontaine C, Dubois G, Duguay Y, Helledie T, Vu-Dac N, Gervois P, Soncin F, Mandrup S, Fruchart JC, Fruchart-Najib J, Staels B. Fontaine C, et al. J Biol Chem. 2003 Sep 26;278(39):37672-80. doi: 10.1074/jbc.M304664200. Epub 2003 Jun 23. J Biol Chem. 2003. PMID: 12821652 - Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock.
Yin L, Wang J, Klein PS, Lazar MA. Yin L, et al. Science. 2006 Feb 17;311(5763):1002-5. doi: 10.1126/science.1121613. Science. 2006. PMID: 16484495 - The role of the orphan nuclear receptor Rev-Erb alpha in adipocyte differentiation and function.
Laitinen S, Fontaine C, Fruchart JC, Staels B. Laitinen S, et al. Biochimie. 2005 Jan;87(1):21-5. doi: 10.1016/j.biochi.2004.12.006. Biochimie. 2005. PMID: 15733732 Review. - The orphan nuclear receptor Rev-erbalpha: a transcriptional link between circadian rhythmicity and cardiometabolic disease.
Fontaine C, Staels B. Fontaine C, et al. Curr Opin Lipidol. 2007 Apr;18(2):141-6. doi: 10.1097/MOL.0b013e3280464ef6. Curr Opin Lipidol. 2007. PMID: 17353661 Review.
Cited by
- Timed use of digoxin prevents heart ischemia-reperfusion injury through a REV-ERBα-UPS signaling pathway.
Vinod M, Berthier A, Maréchal X, Gheeraert C, Boutry R, Delhaye S, Annicotte JS, Duez H, Hovasse A, Cianférani S, Montaigne D, Eeckhoute J, Staels B, Lefebvre P. Vinod M, et al. Nat Cardiovasc Res. 2022 Nov 3;1(11):990-1005. doi: 10.1038/s44161-022-00148-z. Nat Cardiovasc Res. 2022. PMID: 38229609 Free PMC article. - New role for the anandamide metabolite prostaglandin F2α ethanolamide: Rolling preadipocyte proliferation.
Boubertakh B, Courtemanche O, Marsolais D, Di Marzo V, Silvestri C. Boubertakh B, et al. J Lipid Res. 2023 Nov;64(11):100444. doi: 10.1016/j.jlr.2023.100444. Epub 2023 Sep 18. J Lipid Res. 2023. PMID: 37730163 Free PMC article. - Circadian Dysfunction in Adipose Tissue: Chronotherapy in Metabolic Diseases.
Civelek E, Ozturk Civelek D, Akyel YK, Kaleli Durman D, Okyar A. Civelek E, et al. Biology (Basel). 2023 Aug 2;12(8):1077. doi: 10.3390/biology12081077. Biology (Basel). 2023. PMID: 37626963 Free PMC article. Review. - Circadian mechanisms in adipose tissue bioenergetics and plasticity.
Hepler C, Bass J. Hepler C, et al. Genes Dev. 2023 Jun 1;37(11-12):454-473. doi: 10.1101/gad.350759.123. Epub 2023 Jun 26. Genes Dev. 2023. PMID: 37364987 Free PMC article. Review. - The REV-ERB Nuclear Receptors: Timekeepers for the Core Clock Period and Metabolism.
Adlanmerini M, Lazar MA. Adlanmerini M, et al. Endocrinology. 2023 Apr 17;164(6):bqad069. doi: 10.1210/endocr/bqad069. Endocrinology. 2023. PMID: 37149727 Free PMC article. Review.
References
- Ando, H., H. Yanagihara, Y. Hayashi, Y. Obi, S. Tsuruoka, T. Takamura, S. Kaneko, and A. Fujimura. 2005. Rhythmic messenger ribonucleic acid expression of clock genes and adipocytokines in mouse visceral adipose tissue. Endocrinology 1465631-5636. - PubMed
- Balsalobre, A., F. Damiola, and U. Schibler. 1998. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93929-937. - PubMed
- Brady, M. J., F. J. Bourbonais, and A. R. Saltiel. 1998. The activation of glycogen synthase by insulin switches from kinase inhibition to phosphatase activation during adipogenesis in 3T3-L1 cells. J. Biol. Chem. 27314063-14066. - PubMed
- Chawla, A., and M. A. Lazar. 1993. Induction of Rev-ErbAα, an orphan receptor encoded on the opposite strand of the α-thyroid hormone receptor gene, during adipocyte differentiation. J. Biol. Chem. 26816265-16269. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases